Sign Up Today and Learn More About Aprecia Pharmaceuticals Stock

Invest in or calculate the value of your shares in Aprecia Pharmaceuticals or other pre-IPO companies through EquityZen's platform.

Get Started

Aprecia Pharmaceuticals Stock

Aprecia Pharmaceuticals develops precision drug delivery systems and products.

About Aprecia Pharmaceuticals Stock

Founded

2003

Headquarters

Langhorne, PA, US

Total Funding

158M

Aprecia Pharmaceuticals Company develops and manufactures precision drug delivery systems and products. Its products include CustomRelease that provides various time release profiles; ZipDose, a orally dispersing wafers pairing a high dose ceiling with times, taste-masking options, and IR/ER combinations; and NanoDose that is suited for products requiring submilligram doses. The company also offers ImplantaDose, which is suited for post surgical management of infections and associated pain, and sequential release of biomimetic proteins and peptides. Aprecia Pharmaceuticals Company was incorproated in 2003 and is based in Langhorne, Pennsylvania.

Aprecia Pharmaceuticals Management

Leadership team at Aprecia Pharmaceuticals

President and Chief Scientist

Donald Monkhouse

Executive Director

Lawrence Glassmann

Locked Features

Join now and verify your accreditation status to gain access to:

  • Aprecia Pharmaceuticals current valuation
  • Aprecia Pharmaceuticals stock price
  • Available deals in Aprecia Pharmaceuticals and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Aprecia Pharmaceuticals stock?

Accredited investors can buy pre-IPO stock in companies like Aprecia Pharmaceuticals through EquityZen funds. These investments are made available by existing Aprecia Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Aprecia Pharmaceuticals stock?

Shareholders can sell their Aprecia Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."